MedPath

Zetlow-10

Brand Name: Zetlow-10

Generic Name: Ezetimibe

Active
Registration Number

DRP-11354-02

Dosage Form

Tablet

Issuance Date

August 2, 2023

Expiry Date

March 3, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg
PackagingAlu/Alu Blister x 7's (Box of 70's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Lipid Modifying Agent (Cholesterol Absorption Inhibitor)
A
Application
CLIDP Conversion
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

EzetimibeActive
Monograph: Ezetimibe

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform